DK183590A - Fremgangsmaade til reduktion af immunoglobulin e-responser - Google Patents

Fremgangsmaade til reduktion af immunoglobulin e-responser Download PDF

Info

Publication number
DK183590A
DK183590A DK183590A DK183590A DK183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A
Authority
DK
Denmark
Prior art keywords
responses
procedure
reducing immunoglobulin
antagonist
human interleukin
Prior art date
Application number
DK183590A
Other languages
Danish (da)
English (en)
Other versions
DK183590D0 (da
Inventor
Robert L Coffman
Jan Egbert De Vries
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK183590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of DK183590D0 publication Critical patent/DK183590D0/da
Publication of DK183590A publication Critical patent/DK183590A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK183590A 1988-02-02 1990-08-01 Fremgangsmaade til reduktion af immunoglobulin e-responser DK183590A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02
PCT/US1989/000285 WO1989006975A1 (en) 1988-02-02 1989-01-30 Method of reducing immunoglobulin e responses

Publications (2)

Publication Number Publication Date
DK183590D0 DK183590D0 (da) 1990-08-01
DK183590A true DK183590A (da) 1990-09-27

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183590A DK183590A (da) 1988-02-02 1990-08-01 Fremgangsmaade til reduktion af immunoglobulin e-responser

Country Status (20)

Country Link
US (1) US5676940A (ja)
EP (2) EP0327283B1 (ja)
JP (1) JPH03500050A (ja)
KR (1) KR900700132A (ja)
AT (1) ATE93144T1 (ja)
AU (1) AU629536B2 (ja)
CA (1) CA1341477C (ja)
DE (1) DE68908431T2 (ja)
DK (1) DK183590A (ja)
ES (1) ES2058490T3 (ja)
FI (1) FI903827A0 (ja)
HK (1) HK35196A (ja)
HU (1) HU211059B (ja)
IE (1) IE63097B1 (ja)
IL (1) IL89124A (ja)
MY (1) MY107079A (ja)
NZ (1) NZ227812A (ja)
PT (1) PT89573B (ja)
WO (1) WO1989006975A1 (ja)
ZA (1) ZA89766B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
HUT64481A (en) * 1989-12-04 1994-01-28 Schering Corp Method for producing pharmaceutical preparative containing human il-6 antagonist
AU639754B2 (en) * 1989-12-20 1993-08-05 Schering Corporation Antibody antagonists of human interleukin-4
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
ES2614260T3 (es) 2000-05-26 2017-05-30 Immunex Corporation Uso de anticuerpos contra el receptor de interleuquina-4 y composiciones de los mismos
ES2291455T3 (es) 2001-03-12 2008-03-01 Avanir Pharmaceuticals Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
EP0255547A1 (en) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof
JP2724625B2 (ja) * 1987-12-31 1998-03-09 タノックス・バイオシステムズ・インコーポレーテッド ＩｇＥ産出性Ｂリンパ球上の独特な抗原決定基

Also Published As

Publication number Publication date
DK183590D0 (da) 1990-08-01
IL89124A (en) 1994-10-21
HU211059B (en) 1995-10-30
ES2058490T3 (es) 1994-11-01
ATE93144T1 (de) 1993-09-15
IE63097B1 (en) 1995-03-22
ZA89766B (en) 1989-09-27
CA1341477C (en) 2005-03-29
IL89124A0 (en) 1989-08-15
HK35196A (en) 1996-03-08
WO1989006975A1 (en) 1989-08-10
KR900700132A (ko) 1990-08-11
DE68908431D1 (de) 1993-09-23
FI903827A0 (fi) 1990-08-01
AU629536B2 (en) 1992-10-08
JPH03500050A (ja) 1991-01-10
HU891044D0 (en) 1990-11-28
HUT54214A (en) 1991-01-28
EP0327283B1 (en) 1993-08-18
EP0397764A1 (en) 1990-11-22
NZ227812A (en) 1991-09-25
PT89573B (pt) 1994-01-31
DE68908431T2 (de) 1993-12-23
EP0327283A1 (en) 1989-08-09
IE890302L (en) 1989-08-02
AU3038389A (en) 1989-08-25
US5676940A (en) 1997-10-14
MY107079A (en) 1995-09-30
PT89573A (pt) 1989-10-04

Similar Documents

Publication Publication Date Title
DK183590A (da) Fremgangsmaade til reduktion af immunoglobulin e-responser
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
DK81691A (da) Fremgangsmaade til forhindring eller reduktion af eosinofili
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
DK0387873T3 (da) Anti-humant spermaantistof, fremstilling og anvendelse deraf
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment